ENVISION HEALTHCARE CORP (EVHC) financial statements (2021 and earlier)
Company profile
Business Address |
1A BURTON HILLS BOULEVARD NASHVILLE, TN 37215 |
State of Incorp. | |
Fiscal Year End | December 31 |
SIC | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
12/31/2017 | 12/31/2016 | |||
---|---|---|---|---|
ASSETS | ||||
Current Assets | ||||
Cash, cash equivalents, and short-term investments | 312 | 332 | ||
Cash and cash equivalents | 312 | 332 | ||
Restricted cash and investments | 87 | |||
Receivables | 1,406 | 1,755 | ||
Inventory, net of allowances, customer advances and progress billings | 23 | 61 | ||
Inventory | 23 | 61 | ||
Prepaid expense | 74 | 67 | ||
Disposal group, including discontinued operation | 2,752 | |||
Other current assets | 31 | 46 | ||
Other undisclosed current assets | 146 | 63 | ||
Total current assets: | 4,744 | 2,411 | ||
Noncurrent Assets | ||||
Property, plant and equipment | 303 | 595 | ||
Long-term investments and receivables | 157 | 117 | ||
Long-term investments | 157 | 117 | ||
Intangible assets, net (including goodwill) | 11,202 | 13,424 | ||
Goodwill | 7,536 | 8,819 | ||
Intangible assets, net (excluding goodwill) | 3,666 | 4,605 | ||
Other noncurrent assets | 167 | 162 | ||
Total noncurrent assets: | 11,828 | 14,298 | ||
TOTAL ASSETS: | 16,573 | 16,709 | ||
LIABILITIES AND EQUITY | ||||
Liabilities | ||||
Current Liabilities | ||||
Accounts payable and accrued liabilities | 944 | 1,107 | ||
Accounts payable | 62 | 101 | ||
Accrued liabilities | 282 | 393 | ||
Employee-related liabilities | 548 | 561 | ||
Interest and dividends payable | 52 | 51 | ||
Debt | 52 | 47 | ||
Disposal group, including discontinued operation | 399 | |||
Total current liabilities: | 1,395 | 1,154 | ||
Noncurrent Liabilities | ||||
Long-term debt and lease obligation, including: | 6,263 | 5,792 | ||
Other undisclosed long-term debt and lease obligation | 6,263 | 5,792 | ||
Liabilities, other than long-term debt | 468 | 2,192 | ||
Deferred tax liabilities, net | 1,681 | |||
Other liabilities | 150 | 141 | ||
Self insurance reserve | 319 | 371 | ||
Other undisclosed noncurrent liabilities | 1,089 | |||
Total noncurrent liabilities: | 7,821 | 7,984 | ||
Total liabilities: | 9,216 | 9,138 | ||
Temporary equity, carrying amount | 187 | 183 | ||
Stockholders' equity | ||||
Stockholders' equity attributable to parent, including: | 6,527 | 6,731 | ||
Preferred stock | 0 | |||
Additional paid in capital | 6,009 | 5,976 | ||
Accumulated other comprehensive loss | (4) | (0) | ||
Retained earnings | 521 | 754 | ||
Other undisclosed stockholders' equity attributable to parent | 1 | 1 | ||
Stockholders' equity attributable to noncontrolling interest | 642 | 657 | ||
Total stockholders' equity: | 7,169 | 7,388 | ||
TOTAL LIABILITIES AND EQUITY: | 16,573 | 16,709 |
Income statement (P&L) ($ in millions)
12/31/2017 | 12/31/2016 | ||
---|---|---|---|
Revenues | 7,819 | 3,696 | |
Revenue, net | 12,178 | 4,589 | |
Cost of revenue (Cost of Goods and Services Sold) | (223) | (203) | |
Gross profit: | 7,597 | 3,493 | |
Operating expenses | (7,650) | (3,349) | |
Other undisclosed operating income | 243 | 232 | |
Operating income: | 189 | 376 | |
Nonoperating income | 21 | 1 | |
Investment income, nonoperating | 10 | ||
Other nonoperating income | 11 | 1 | |
Interest and debt expense | (231) | (173) | |
Income (loss) from continuing operations before equity method investments, income taxes: | (21) | 205 | |
Other undisclosed loss from continuing operations before income taxes | (10) | ||
Income (loss) from continuing operations before income taxes: | (31) | 205 | |
Income tax benefit | 497 | 1 | |
Income from continuing operations: | 466 | 206 | |
Loss from discontinued operations | (492) | ||
Net income (loss): | (26) | 206 | |
Net loss attributable to noncontrolling interest | (202) | ||
Other undisclosed net loss attributable to parent | (224) | ||
Net loss attributable to parent: | (228) | (19) | |
Preferred stock dividends and other adjustments | (5) | (9) | |
Net loss available to common stockholders, basic: | (233) | (28) | |
Other undisclosed net income available to common stockholders, diluted | 492 | ||
Net income (loss) available to common stockholders, diluted: | 259 | (28) |
Comprehensive Income ($ in millions)
12/31/2017 | 12/31/2016 | ||
---|---|---|---|
Net income (loss): | (26) | 206 | |
Other undisclosed comprehensive loss | (4) | (0) | |
Comprehensive income (loss): | (30) | 205 | |
Comprehensive loss, net of tax, attributable to noncontrolling interest | (202) | (224) | |
Comprehensive loss, net of tax, attributable to parent: | (232) | (19) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.